Levin Group to partner with San Diego-based pharmaceutical company

    Dec. 9, 2009
    Levin Group and Novalar will develop a program to show dental professionals the value of OraVerse as an effective routine treatment in cases in which anesthesia reversal is appropriate.

    Levin Group has announced it has been engaged by Novalar Pharmaceuticals based in San Diego, Calif.

    An international dental practice management consulting firm, Levin Group works with numerous dental corporations to help them market their products and technologies and integrate them into dental practices.

    The company will partner with Novalar to develop a program to show dental professionals the value of OraVerse as an effective routine treatment in cases where anesthesia reversal is appropriate.

    OraVerse is used after restorative dental procedures in which lingering numbness is problematic. OraVerse is an anesthesia reversal agent that restores normal sensation quickly and accelerates return to normal function so patients can speak, smile, and drink normally.

    Levin Group has partnered with multiple companies to develop materials to assist in the implementation of products.

    For more information about Levin Group, visit Levin Group.

    To read more about Levin Group, go to Levin Group.

    To comment on this topic, go to PennWell Dental Community site.